zum Inhalt springen

Fachbereich Veterinärmedizin


Service-Navigation

    Publikationsdatenbank

    CEACAM1 regulates CD8+ T cell immunity and protects from severe pathology during Citrobacter rodentium induced colitis (2020)

    Art
    Zeitschriftenartikel / wissenschaftlicher Beitrag
    Autoren
    Zöller, Julia
    Ebel, Jana-Fabienne
    Khairnar, Vishal
    Schmitt, Verena
    Klopfleisch, Robert (WE 12)
    Meiners, Jana
    Seiffart, Virginia
    Hansen, Wiebke
    Buer, Jan
    Singer, Bernhard B.
    Lang, Karl S.
    Westendorf, Astrid M.
    Quelle
    Gut microbes
    Bandzählung: 11
    Heftzählung: 6
    Seiten: 1790 – 1805
    ISSN: 1949-0976
    Sprache
    Englisch
    Verweise
    URL (Volltext): https://www.tandfonline.com/doi/epub/10.1080/19490976.2020.1775464?needAccess=true
    DOI: 10.1080/19490976.2020.1775464
    Pubmed: 32521208
    Kontakt
    Institut für Tierpathologie

    Robert-von-Ostertag-Str. 15
    14163 Berlin
    +49 30 838 62450
    pathologie@vetmed.fu-berlin.de

    Abstract / Zusammenfassung

    The incidence of gastrointestinal infections continues to increase, and infectious colitis contributes significantly to morbidity and mortality worldwide. Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) has been discovered to be strongly involved in the intestinal homeostasis. However, whether intestinal CEACAM1 expression has an impact on the control of infectious colitis remains elusive. Citrobacter rodentium (C. rodentium) is a gram-negative enteric pathogen that induces colonic inflammation in mice, with a critical role for CD4+ T cell but not CD8+ T cell immunity to primary infection. Here, we show that Ceacam1-/- mice are much more susceptible to C. rodentium infection than wildtype mice, which is mediated by a defect in the intestinal barrier and, surprisingly, by a dysregulated CD8+ T cell but not CD4+ T cell response in the colon. CEACAM1 expression is essential for the control of CD8+ T cell immunity, as CEACAM1 deficiency during C. rodentium infection inhibits CD8+ T cell exhaustion. We conclude that CEACAM1 is an important regulator of CD8+ T cell function in the colon, and blocking CEACAM1 signaling to activate CD8+ T cells may have unforeseen side effects.